LncRNA EILA Promotes CDK4/6 Inhibitor Resistance in Breast Cancer by Stabilizing Cyclin E1 Protein

By
Bob
-
0
77
Researchers reported that a cyclin E1–interacting lncRNA was up-regulated in CDK4/6 inhibitor (CDK4/6i)-resistant breast cancer cells and contributed to CDK4/6i resistance by stabilizing cyclin E1 protein.
[Science Advances]
Full Article